ArticleEndocrine, metabolic & immune disorders drug targets2026

Identifying AIM2 Circulating Methylation Levels as a Novel Diagnostic Biomarker for Rheumatoid Arthritis Using Targeted DNA Methylation Sequencing.

Jianan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.